East Brunswick, NJ, United States of America

Liat Mintz

USPTO Granted Patents = 18 (Patent Applications = 5)

CIPO Patents = 6

EPO Patents = 8 (Patent Applications = 5)

Average Co-Inventor Count = 1.9

ph-index = 6

Forward Citations = 404(Granted Patents)

Location History:

Ramat Hasharon, IL (2003 - 2004)
East Brunswick, NJ (US) (2007 - 2020)
Cambridge, MA (US) (2013 - 2021)

Company Filing History:

6 out of 60

Compugen Ltd. Corporation

patents

5 out of 444

Alnylam Pharmaceuticals, Inc.

4. 5 out of 832,891

Other

patents

Years Active: 2003-2021

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10982212 - Conserved HBV and HCV sequences useful for gene silencing (2021-04-20),

2. 10526383 - Ghrelin splice variant for treating neuronal damage, neurodegenerative disease, parkinsons disease, alzheimers disease, and/or depression (2020-01-07),

3. 9982263 - Conserved HBV and HCV sequences useful for gene silencing (2018-05-29),

4. 9200281 - Conserved HBV and HCV sequences useful for gene silencing (2015-12-01),

5. 8653022 - Use of ghrelin splice variant for treating hypercholesterolemia and/or high cholesterol and/or high cholesterol complication and/or lipemia and/or lipemia complication and/or coronary heart disease and/or weight management and/or diabetes and/or hyperglycemia (2014-02-18),

6. 8575327 - Conserved HBV and HCV sequences useful for gene silencing (2013-11-05),

7. 8350021 - Conserved HBV and HCV sequences useful for gene silencing (2013-01-08),

8. 8088730 - Ghrelin variant protein (2012-01-03),

9. 7981860 - Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation (2011-07-19),

10. 7858744 - Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance (2010-12-28),

11. 7763707 - Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation (2010-07-27),

12. 7745391 - Human thrombospondin polypeptide (2010-06-29),

13. 7678769 - Hepatocyte growth factor receptor splice variants and methods of using same (2010-03-16),

14. 7176292 - Ghrelin variant protein (2007-02-13),

15. 6783954 - VEGF nucleic acid and amino acid sequences (2004-08-31),

Sure, here is an article about inventor Liat Mintz:

**Title: Unveiling the Innovative Mind of Liat Mintz**

Introduction:

In the realm of innovation and cutting-edge research, inventor Liat Mintz stands out as a visionary figure whose groundbreaking work has left a lasting impact. Hailing from East Brunswick, NJ (US), Mintz has made significant contributions to the field of medicine through his inventive patents and collaborative endeavors.

Latest Patents:

Liat Mintz's latest patents showcase his dedication to advancing treatments for neurological disorders and metabolic conditions. One of his notable inventions involves the use of a ghrelin splice variant for treating neuronal damage, neurodegenerative diseases, Parkinson's disease, Alzheimer's disease, depression, and more. Additionally, Mintz has pioneered the use of this variant for addressing hypercholesterolemia, high cholesterol complications, lipemia, coronary heart disease, weight management, diabetes, and hyperglycemia.

Career Highlights:

Mintz has honed his expertise through his tenure at esteemed companies such as Compugen Ltd., where he has demonstrated a deep commitment to research and development. His innovative spirit and relentless pursuit of solutions have solidified his reputation as a trailblazer in the scientific community.

Collaborations:

Throughout his career, Liat Mintz has had the privilege of collaborating with talented individuals who share his passion for innovation. Noteworthy colleagues such as Kinneret Savitzky and Sharon Engel have enriched his professional journey, fostering a culture of creativity and exploration.

Conclusion:

In conclusion, inventor Liat Mintz's inventive prowess and dedication to advancing medical treatments have positioned him as a luminary in the world of innovation. His groundbreaking patents and collaborative efforts underscore his commitment to pushing the boundaries of scientific discovery, shaping a brighter future for healthcare and beyond.

This text is generated by artificial intelligence and may not be accurate.